{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:47:41Z","timestamp":1769845661582,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:00:00Z","timestamp":1552176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jfma.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T14:29:11Z","timestamp":1553524151000},"page":"1193-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia"],"prefix":"10.1016","volume":"118","author":[{"given":"Shin-Yu","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Fan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Jen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2019.03.007_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V56.3.388.388","article-title":"Studies on levamisole-induced agranulocytosis","volume":"56","author":"Thompson","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2019.03.007_bib2","first-page":"1721","article-title":"Adverse reactions to levamisole","volume":"62","author":"Symoens","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.jfma.2019.03.007_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.1994.03510360061038","article-title":"Agranulocytosis","volume":"271","author":"Young","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2019.03.007_bib4","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","article-title":"Adverse effects of levamisole in cocaine users: a review and risk assessment","volume":"91","author":"Brunt","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jfma.2019.03.007_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14740330902784162","article-title":"Recognition and management of drug-induced blood-cytopenias: the example of idiosyncratic drug-induced thrombocytopenia","volume":"8","author":"Andres","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jfma.2019.03.007_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/pds.2630020706","article-title":"The drug etiology of agranulocytosis: an update of the International agranulocytosis and aplastic anemia study","volume":"2","author":"Kaufman","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jfma.2019.03.007_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/etm.2014.1817","article-title":"A patient with agranulocytosis following the discontinuation of methimazole treatment for 4 months: a case report","volume":"8","author":"Bai","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"Moertel","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib11","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/1097-0142(19801115)46:10<2185::AID-CNCR2820461015>3.0.CO;2-5","article-title":"Cellular immune modulation after a single high dose of levamisole in patients with carcinoma","volume":"46","author":"Lewinski","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.jfma.2019.03.007_bib12","first-page":"31","article-title":"Potentiation of interleukin-2 activity by levamisole and imidazole","volume":"4","author":"Redondo","year":"1978","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jfma.2019.03.007_bib13","first-page":"31","article-title":"Experience and recommendations for treatment schedule of levamisole to rheumatoid arthritis","volume":"4","author":"Veys","year":"1978","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfma.2019.03.007_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0030-4220(82)90482-0","article-title":"Levamisole in the treatment of erythema multiforme: a double-blind trial in 14 patients","volume":"53","author":"Lozoda","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jfma.2019.03.007_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0030-4220(82)90212-2","article-title":"Pemphigus vulgaris: a study of six cases treated with levamisole and prednisone","volume":"54","author":"Lozoda","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jfma.2019.03.007_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0714.1978.tb01608.x","article-title":"Double-blind study of levamisole therapy in recurrent aphthous stomatitis","volume":"7","author":"Olson","year":"1978","journal-title":"J Oral Pathol"},{"key":"10.1016\/j.jfma.2019.03.007_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1079-2104(05)80255-0","article-title":"Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus, A 6-year prospective follow-up study","volume":"80","author":"Lu","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jfma.2019.03.007_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1079-2104(98)90370-5","article-title":"Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers, A 3-year open clinical trial and follow-up study","volume":"86","author":"Lu","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jfma.2019.03.007_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5021\/ad.2009.21.3.250","article-title":"Levamisole monotherapy for oral lichen planus","volume":"21","author":"Won","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jfma.2019.03.007_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0714.1994.tb01108.x","article-title":"Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus","volume":"23","author":"Sun","year":"1994","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jfma.2018.01.021","article-title":"Oral lichen planus-Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management","volume":"117","author":"Chiang","year":"2018","journal-title":"J Fla Med Assoc"},{"key":"10.1016\/j.jfma.2019.03.007_bib22","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan","volume":"98","author":"Nakamura","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2019.03.007_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000448586","article-title":"Periodic granulocyte count measuring is useful for detecting asymptomatic agranulocytosis in antithyroid drug-treated patients with Graves' disease","volume":"5","author":"Nakamura","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jfma.2019.03.007_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/105072504323150787","article-title":"Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis","volume":"14","author":"Tajiri","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.jfma.2019.03.007_bib26","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0755-4982(04)98884-7","article-title":"Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis, A study of 91 patients from a single center","volume":"33","author":"Maloisel","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.jfma.2019.03.007_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management","volume":"17","author":"Vicente","year":"2007","journal-title":"Drugs R"},{"key":"10.1016\/j.jfma.2019.03.007_bib28","first-page":"544","article-title":"Antithyroid agents related agranulocytosis: literature review","volume":"37","author":"Andres","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfma.2019.03.007_bib29","first-page":"99","article-title":"Medication dyes as a source of drug allergy","volume":"12","author":"Swertick","year":"2013","journal-title":"J Drugs Dermatol JDD"},{"key":"10.1016\/j.jfma.2019.03.007_bib30","first-page":"22","article-title":"Pharmaceutical excipients: a review","volume":"1","author":"Shilpa","year":"2012","journal-title":"Int J Pharm Biol Chem"},{"key":"10.1016\/j.jfma.2019.03.007_bib31","first-page":"24","article-title":"Excipient-related adverse drug reactions: a clinical approach","volume":"28","author":"Strauss","year":"2015","journal-title":"Curr Allergy Clin Immunol"},{"key":"10.1016\/j.jfma.2019.03.007_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000232788","article-title":"Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies","volume":"65","author":"Hodinka","year":"1981","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jfma.2019.03.007_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2014-02-482612","article-title":"How we evaluate and treat neutropenia in adults","volume":"124","author":"Gibson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2019.03.007_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3371\/1935-1232.10.3.163","article-title":"A quide to the management of clozapine- related tolerability and safety concerns","volume":"10","author":"Citrome","year":"2016","journal-title":"Clin Schizophrenia Relat Psychoses"},{"key":"10.1016\/j.jfma.2019.03.007_bib35","first-page":"279","article-title":"Immune and toxic mechanisms in drug-induced agranulocytosis","volume":"10","author":"Pisciotta","year":"1973","journal-title":"Semin Hematol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461930124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461930124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T09:29:40Z","timestamp":1663147780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966461930124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S092966461930124X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2019.03.007","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}